Is Acepromazine Safe for Dogs? Side Effects & Risks

Acepromazine is one of the most widely used sedatives in veterinary medicine, and for most dogs it is considered safe at appropriate doses. That does not mean it is risk-free. The drug reliably lowers blood pressure, can cause significant body temperature drops under anesthesia, and affects blood cell counts by pooling red blood cells in the spleen. Certain breeds carry a genetic mutation that makes them far more sensitive to its effects. Understanding what acepromazine actually does in a dog’s body, and where the real risks lie, matters more than a simple yes-or-no safety verdict.

What Acepromazine Does and Why Vets Use It

Acepromazine belongs to the phenothiazine class of tranquilizers. It works by blocking dopamine receptors in the brain, which produces sedation and muscle relaxation. It does not provide any pain relief, and it has no reversal agent, meaning once the drug is given, you have to wait for it to wear off on its own.

1PubMed Central. Evaluation of anesthesia produced by ketofol in acepromazine- or medetomidine-sedated dogs

Veterinarians commonly use acepromazine as a pre-anesthetic, giving it before surgery to calm a dog and reduce the amount of general anesthesia needed. It is also used for short-term sedation during stressful events like vet visits, grooming, or travel. When combined with opioids like methadone, the sedation effect is substantially stronger than either drug alone, making the combination a standard pre-surgical protocol.

2PubMed. Effects of methadone, alone or in combination with acepromazine or xylazine, on sedation and physiologic values in dogs

Oral transmucosal delivery, where the liquid is applied to the gums rather than swallowed, produces measurably higher sedation scores compared to controls in a hospital setting. Heart rate and blood pressure both drop after this form of administration, confirming the drug is absorbed effectively through the mouth lining.

3Wiley Online Library. Oral transmucosal administration of acepromazine to healthy dogs leads to increased sedation scores in a hospital setting

Cardiovascular Side Effects

The most significant and well-documented risk of acepromazine is its effect on the cardiovascular system. The drug is a potent alpha-adrenergic blocker, which means it relaxes blood vessel walls. This causes blood pressure to drop, sometimes substantially. In a dose-escalation study in conscious dogs, acepromazine at all tested doses significantly decreased mean arterial pressure by up to about 17%. Stroke index, a measure of how much blood the heart pumps per beat, dropped by up to roughly 16%. Arterial oxygen content fell by up to around 21%.

4PubMed. Hemodynamic, respiratory and sedative effects of progressively increasing doses of acepromazine in conscious dogs

These drops happen because the drug reduces cardiac output rather than by changing vascular resistance. For a healthy young dog, this blood pressure dip is usually manageable. But for a dog that is already dehydrated, has heart disease, is in shock, or is losing blood, the additional cardiovascular depression can become dangerous. This is why acepromazine is generally avoided in critically ill or hemodynamically unstable patients. The lack of a reversal agent compounds the concern: if the blood pressure drops too far, the veterinary team cannot simply “undo” the drug’s effects and must instead support the dog with intravenous fluids, vasopressors, or other interventions while waiting for the acepromazine to metabolize.

Body Temperature and Hypothermia Risk

Acepromazine’s blood-vessel-relaxing properties also interfere with a dog’s ability to regulate body temperature. When blood vessels dilate, heat escapes from the body’s core to the skin surface more easily. Under general anesthesia, this becomes a real clinical concern. A study comparing warming techniques in anesthetized dogs found that dogs premedicated with acepromazine experienced a significantly greater drop in rectal temperature from baseline compared to those premedicated with dexmedetomidine, with a mean difference of about 0.2°C.

5PLoS ONE. Comparison of two active warming techniques on body temperature in healthy, anesthetized dogs premedicated with acepromazine or dexmedetomidine: A pilot study

A fraction of a degree might sound trivial, but in a small dog already prone to heat loss during a long surgery, these incremental drops can push body temperature into hypothermic territory. Hypothermia slows drug metabolism, delays recovery from anesthesia, and increases the risk of surgical complications. Veterinary teams routinely use warming blankets and heated fluid lines for dogs under anesthesia, but owners of toy breeds and very lean dogs should be aware that acepromazine adds an extra layer of temperature-regulation difficulty.

Effects on Blood Cells and the Spleen

One side effect that can alarm owners, and occasionally mislead veterinarians running blood work, is acepromazine’s impact on red blood cell counts. The drug causes the spleen to enlarge and sequester a portion of the circulating red blood cells. A study using Doppler ultrasound confirmed that acepromazine administration led to decreased red blood cell count, hemoglobin, and packed cell volume, along with a measurable increase in the diameter of the spleen.

6PubMed. Hematological and splenic Doppler ultrasonographic changes in dogs sedated with acepromazine or xylazine

This effect is reversible once the drug wears off, and it generally does not cause clinical problems in healthy dogs. The practical issue is interpretation of lab results: if blood is drawn from a dog that was recently sedated with acepromazine, the packed cell volume may read artificially low, potentially triggering unnecessary concern about anemia. Veterinarians who know the dog received acepromazine will account for this, but it is worth being aware of if your dog’s blood work looks unexpectedly off after a sedated procedure.

Breed-Specific Genetic Sensitivity

Some herding breeds, most famously Collies and Australian Shepherds, carry a mutation in the ABCB1 gene (formerly known as the MDR1 gene). This gene codes for a protein that helps pump certain drugs out of the brain. When the protein does not work properly, drugs that would normally be kept at controlled levels in the central nervous system can accumulate to much higher concentrations, producing exaggerated effects.

A controlled study looking specifically at acepromazine in dogs with known ABCB1 genotypes found that dogs homozygous for the mutation (carrying two copies of the defective gene) had significantly higher sedation scores after intravenous acepromazine than dogs with normal gene function. Dogs with just one copy of the mutation did not show a statistically significant difference.

7PubMed Central. The Effect of the Canine ABCB1 ‐1Δ Mutation on Sedation after Intravenous Administration of Acepromazine

This means that dogs with two copies of the ABCB1 mutation can become profoundly sedated at doses that would produce only moderate sedation in a genetically normal dog. Many veterinarians will reduce the dose for known carriers, and some avoid acepromazine altogether in these dogs. Breeds commonly affected include Collies, Australian Shepherds, Shetland Sheepdogs, Long-haired Whippets, and several others. Genetic testing is commercially available and inexpensive, and if you own a herding breed or mixed-breed dog with herding ancestry, knowing your dog’s ABCB1 status before any sedation event is worthwhile.

The Seizure Myth

For decades, a widespread belief among veterinarians held that acepromazine lowers the seizure threshold and should never be given to dogs with a history of seizures. This idea was taught in textbooks and passed through clinical practice as an absolute contraindication. The actual clinical evidence tells a different story.

A retrospective study evaluated 36 dogs with a prior history of seizures that received acepromazine for tranquilization during hospitalization. None of those 36 dogs had a seizure within 16 hours of receiving the drug. In a separate group of dogs that were actively seizing, acepromazine administration was followed by seizure cessation lasting 1.5 to 8 hours in most cases, and seizures did not recur at all in two dogs.

8PubMed. A retrospective study on the use of acepromazine maleate in dogs with seizures

A second clinical study reached a similar conclusion, finding no observed correlation between acepromazine administration and recurrence of seizure activity during hospitalization in dogs with seizure histories. Out of 27 dogs evaluated, none seized after receiving the drug within an average observation period of over 16 hours.

9Journal of Veterinary Emergency and Critical Care. Administration of acepromazine maleate to 31 dogs with a history of seizures

A third study similarly concluded there was no clinical evidence that acepromazine at standard dosages was associated with increased seizure activity in dogs with seizure disorders.

10Journal of Veterinary Emergency and Critical Care. THE USE OF ACEPROMAZINE IN DOGS WITH A HISTORY OF SEIZURES

These are retrospective studies with relatively small numbers, so they cannot definitively prove acepromazine is safe for every epileptic dog. But the longstanding blanket contraindication appears to be based more on tradition than on documented clinical harm. Some veterinary neurologists have begun reconsidering this prohibition, particularly in situations where acepromazine’s sedation could be beneficial, such as calming a dog whose seizures are triggered by excitement or stress. If your dog has epilepsy and a veterinarian recommends acepromazine, the decision is more nuanced than older guidelines suggested.

Sedation Without Anxiolysis

One of the most important things for dog owners to understand about acepromazine is what it does not do. The drug immobilizes and sedates, but it does not meaningfully reduce fear or anxiety. A dog given acepromazine before a thunderstorm or fireworks display may appear calm because it cannot move or react normally, but there is evidence that the internal experience of fear persists. The dog is essentially aware and frightened but unable to respond.

This distinction matters because acepromazine was once routinely prescribed for noise phobias and separation anxiety. Current veterinary behavioral medicine has largely moved away from this practice, favoring drugs that genuinely affect the emotional experience of fear, such as trazodone, gabapentin, or benzodiazepines for acute situational anxiety. The concern is not just that acepromazine fails to reduce anxiety but that it may worsen the animal’s experience by removing its ability to cope through movement or escape behavior while leaving the distress itself intact.

If your veterinarian suggests acepromazine for anxiety rather than for a pre-surgical or procedural purpose, it is reasonable to ask about alternatives that target the anxiety itself. This is an area where veterinary practice has shifted considerably in the past two decades, and some older-trained practitioners may still default to acepromazine out of long habit.

The Epinephrine Reversal Problem

A drug interaction that every dog owner should know about involves acepromazine and epinephrine (adrenaline). The combination can produce a paradoxical reaction called “epinephrine reversal,” where instead of raising blood pressure the way epinephrine normally would, the blood pressure drops further. This happens because acepromazine blocks the alpha-adrenergic receptors that epinephrine would normally stimulate to constrict blood vessels. With those receptors blocked, only the beta-adrenergic effects of epinephrine remain, and some of those effects dilate blood vessels, making the hypotension worse.

This is clinically relevant in emergency situations. If a dog sedated with acepromazine goes into anaphylactic shock, for example from a vaccine reaction or an insect sting, the standard emergency protocol of administering epinephrine may not work as expected and could worsen the crisis. Veterinarians managing dogs under acepromazine sedation are aware of this and will choose alternative vasopressors if blood pressure support is needed. For owners, the practical takeaway is to make sure any emergency veterinarian treating your dog knows if acepromazine was recently administered.

No Reversal Agent

Unlike some other veterinary sedatives, acepromazine cannot be reversed once given. Dexmedetomidine, for instance, has a specific reversal agent (atipamezole) that can rapidly wake a dog up. Acepromazine has no such antidote.

1PubMed Central. Evaluation of anesthesia produced by ketofol in acepromazine- or medetomidine-sedated dogs

The duration of effect varies depending on the dose, the route of administration, and the individual dog, but sedation typically lasts several hours and can persist for considerably longer in older dogs, dogs with liver disease, or dogs carrying the ABCB1 mutation. If an adverse reaction occurs, supportive care (IV fluids, warming, monitoring) is the only option while waiting for the drug to metabolize. This irreversibility is a meaningful disadvantage compared to newer sedation protocols, and it is one reason some veterinary practices have shifted toward reversible alternatives for routine sedation when the clinical situation allows.

Who Should Avoid Acepromazine

Despite being broadly safe in healthy dogs, acepromazine carries specific contraindications and situations where the risk-benefit calculation tips unfavorable:

  • Dogs in shock or with severe dehydration: The blood pressure drop can become life-threatening in a patient whose cardiovascular system is already compromised.
  • Brachycephalic breeds: Bulldogs, Pugs, and other flat-faced breeds are more prone to upper airway obstruction. Acepromazine’s relaxation of upper airway muscles can worsen this tendency, though many veterinarians do still use it cautiously in these dogs at reduced doses.
  • Dogs with known liver disease: Acepromazine is metabolized by the liver. Impaired liver function can lead to prolonged and exaggerated sedation.
  • Very young puppies and geriatric dogs: Both populations metabolize drugs more slowly and may experience longer or deeper sedation than expected.
  • Dogs with ABCB1 mutations (two copies): As discussed, profoundly increased sensitivity requires substantial dose reduction or avoidance.
  • Dogs about to undergo procedures where rapid reversal might be needed: The lack of an antidote makes acepromazine a poor choice when unpredictable complications could require a quick wake-up.

For dogs outside these categories, acepromazine remains a reliable and inexpensive sedation option. Its long track record in veterinary medicine means its effects are well characterized, and veterinarians are experienced at managing its predictable side-effect profile.

Paradoxical Excitement and Unexpected Behavioral Reactions

While acepromazine generally produces calm sedation, some dogs exhibit paradoxical excitement, becoming agitated, vocal, or hyperactive instead of relaxed. A study examining midazolam-induced behavioral reactions in dogs found that adding acepromazine to the protocol did not prevent paradoxical behavioral changes including excitation, panting, pacing, restlessness, licking, chewing, and vocalization.

11PubMed Central. Effects of acepromazine or methadone on midazolam-induced behavioral reactions in dogs

Paradoxical reactions are not common, but they are well recognized and unpredictable. They tend to occur more in dogs that are already highly aroused or fearful when the drug is administered. Some individual dogs simply seem prone to the effect regardless of circumstances. If your dog has had a paradoxical reaction to acepromazine in the past, let your veterinarian know before any future sedation. The reaction does not typically indicate a dangerous allergy, but it means the drug is not achieving its purpose and an alternative should be used.

How Acepromazine Compares to Newer Options

Veterinary sedation has expanded considerably beyond acepromazine. Dexmedetomidine offers deeper sedation with full reversibility. Trazodone and gabapentin provide genuine anxiolysis for situational fears. Sileo (dexmedetomidine oromucosal gel) is specifically labeled for noise aversion in dogs. These newer options have not made acepromazine obsolete, but they have narrowed the situations where it is the best choice.

Acepromazine’s strengths are its low cost, its long history of use, its reliable sedation when combined with opioids for pre-anesthetic protocols, and its anti-nausea properties, which can be useful for dogs that vomit from car sickness or from opioid administration. Its weaknesses are the irreversibility, the cardiovascular depression, the lack of true anxiety relief, and the genetic sensitivity issue in herding breeds. Veterinarians weigh these factors for each individual patient, and the “best” sedative depends entirely on the clinical scenario, the dog’s health status, and the goal of sedation.

If your dog has an upcoming procedure or you are looking for help with travel anxiety or noise fears, asking your veterinarian specifically about the purpose of the sedation and whether a newer alternative might be a better fit for your dog’s particular situation is a reasonable and increasingly common conversation to have.